Search results
Showing 7411 to 7425 of 8212 results
Violence and aggression: short-term management in mental health, health and community settings
Discontinued Reference number: GID-NG10397
In development Reference number: GID-TA11771 Expected publication date: TBC
Discontinued Reference number: GID-MT510
Abicipar pegol for treating wet age-related macular degeneration [ID1533]
In development Reference number: GID-TA10511 Expected publication date: TBC
Discontinued Reference number: GID-NG10374
SeQuent Please Neo balloon catheter for in-stent coronary restenosis - update of MTG1 (discontinued)
Discontinued Reference number: GID-MT516
In development Reference number: GID-TA11745 Expected publication date: TBC
Vosoritide for treating achondroplasia in people 4 months and over [ID6488]
In development Reference number: GID-TA11528 Expected publication date: TBC
In development Reference number: GID-TA11607 Expected publication date: 13 January 2027
Discontinued Reference number: GID-TAG409
Discontinued Reference number: GID-TAG410
Sotagliflozin with insulin for treating type 1 diabetes (TA622)
NICE has withdrawn this guidance. This is because the company is no longer marketing sotagliflozin (Zynquista) and its marketing authorisation has been withdrawn.
We have moved Medical technologies guidance 39 to become HealthTech guidance 488. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Curos for preventing infections when using needleless connectors (MTG44)
We have moved Medical technologies guidance 44 to become HealthTech guidance 510. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
We have moved Medical technologies guidance 46 to become HealthTech guidance 533. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.